EXACT Therapeutics AS Logo

EXACT Therapeutics AS

Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.

EXTX | OL

Overview

Corporate Details

ISIN(s):
NO0010852205 (+1 more)
LEI:
2138006ZE5JAL39AGD55
Country:
Norway
Address:
Østre Aker vei 19, 0581 Oslo
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing a technology platform for targeted therapeutic enhancement called Acoustic Cluster Therapy (ACT®). The company's vision is to become a leading precision medicine company by utilizing ultrasound to improve drug delivery in oncology. The proprietary ACT® platform uses a biomechanical mode of action to increase the uptake of co-administered drugs from blood vessels into the surrounding cancer tissue without damaging capillary walls. This technology is designed to be compatible with existing hospital ultrasound systems, requires no drug reformulation, and has shown potential in targeting tumors and crossing the blood-brain barrier. A key focus area is pancreatic cancer, with a clinical program in Phase 2 trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 08:00
Interim Report
EXACT Therapeutics first half 2025 interim results - Attachment: EXACT Therape…
English 743.7 KB
2025-09-25 08:00
Report Publication Announcement
EXACT Therapeutics first half 2025 interim results
English 1.4 KB
2025-09-18 08:00
Regulatory News Service
EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conf…
English 2.0 KB
2025-09-09 08:00
Regulatory News Service
EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth Inter…
English 2.0 KB
2025-08-12 08:30
Regulatory News Service
EXACT Therapeutics to Present at the European Society for Medical Oncology (ESM…
English 1.8 KB
2025-08-11 11:08
Report Publication Announcement
Financial calendar
English 430 bytes
2025-07-08 08:30
Legal Proceedings Report
EXACT Therapeutics announces grant of core patent in the U.S.
English 1.9 KB
2025-06-24 08:00
Regulatory News Service
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients w…
English 3.0 KB
2025-06-13 12:09
Director's Dealing
EXACT Therapeutics AS: Primary insider notification - Attachment: Notification …
English 41.4 KB
2025-06-13 12:09
Board/Management Information
EXACT Therapeutics AS: Primary insider notification
English 1.3 KB
2025-06-13 12:05
Post-Annual General Meeting Information
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 - Attachme…
Norwegian 729.7 KB
2025-06-13 12:05
Post-Annual General Meeting Information
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025
English 1.3 KB
2025-06-04 09:20
Proxy Solicitation & Information Statement
EXACT Therapeutics AS – Information regarding voting at the Annual General Meet…
English 1.7 KB
2025-05-28 14:53
Pre-Annual General Meeting Information
EXACT Therapeutics AS - Notice of Annual General Meeting 2025 - Attachment: AGM…
Norwegian 1.1 MB
2025-05-28 14:53
Pre-Annual General Meeting Information
EXACT Therapeutics AS - Notice of Annual General Meeting 2025
English 1.4 KB

Automate Your Workflow. Get a real-time feed of all EXACT Therapeutics AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EXACT Therapeutics AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.